Jonathan Yong
Stock Analyst at UBS
(2.73)
# 1,781
Out of 5,169 analysts
95
Total ratings
62.96%
Success rate
12.22%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $13.56 | +25.37% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.53 | +226.80% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $1.88 | +59.57% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $13.60 | -11.76% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.17 | +268.66% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.86 | +193.45% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $23.15 | -39.52% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.12 | +31.29% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $16.25 | +96.92% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $17.93 | +485.61% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $99.68 | -19.74% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $265.84 | -13.11% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.42 | +398.15% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $211.87 | -52.80% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $920.35 | -51.11% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.07 | +1,021.50% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.59 | +1,152.24% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $19.45 | -12.60% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $148.63 | +135.48% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $23.20 | +309.48% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.53 | +455.56% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $21.59 | +89.90% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.04 | +179.61% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $76.95 | +10.46% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $195.23 | -25.22% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $36.16 | +193.14% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $189.58 | -17.19% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $264.61 | +39.07% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $170.42 | +272.61% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $73.02 | +60.23% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $19.83 | +51.29% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $502.05 | -40.64% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $203.21 | -53.25% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $284.33 | +74.09% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $13.56
Upside: +25.37%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.53
Upside: +226.80%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $1.88
Upside: +59.57%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $13.60
Upside: -11.76%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.17
Upside: +268.66%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.86
Upside: +193.45%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $23.15
Upside: -39.52%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.12
Upside: +31.29%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.25
Upside: +96.92%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $17.93
Upside: +485.61%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $99.68
Upside: -19.74%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $265.84
Upside: -13.11%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.42
Upside: +398.15%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $211.87
Upside: -52.80%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $920.35
Upside: -51.11%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.07
Upside: +1,021.50%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.59
Upside: +1,152.24%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $19.45
Upside: -12.60%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $148.63
Upside: +135.48%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $23.20
Upside: +309.48%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.53
Upside: +455.56%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $21.59
Upside: +89.90%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.04
Upside: +179.61%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $76.95
Upside: +10.46%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $195.23
Upside: -25.22%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $36.16
Upside: +193.14%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $189.58
Upside: -17.19%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $264.61
Upside: +39.07%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $170.42
Upside: +272.61%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $73.02
Upside: +60.23%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $19.83
Upside: +51.29%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $502.05
Upside: -40.64%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $203.21
Upside: -53.25%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $284.33
Upside: +74.09%